Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.51 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.49 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.49 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.47 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.47 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.47 |
| ▸ | NPY1R | P25929 | 1/20 | 0.47 |
| ▸ | NPY2R | P49146 | 1/20 | 0.47 |
| ▸ | NPY4R | P50391 | 1/20 | 0.47 |
| ▸ | LAP3 | P28838 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.46 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.46 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.46 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29531457 | 1.00 | GSR (0.51) | GSRDPP8DPP9DPP7ALDH1A1 | |
| SCHEMBL20818872 | 1.00 | GSR (0.51) | GSRDPP8DPP9DPP7ALDH1A1 | |
| SCHEMBL30397735 | 0.97 | NPY1R (0.50) | GSRDPP8DPP9DPP7ALDH1A1 | |
| SCHEMBL29740735 | 0.97 | NPY1R (0.50) | GSRDPP8DPP9DPP7ALDH1A1 | |
| SCHEMBL29682467 | 0.96 | NPY4R (0.52) | GSRDPP8DPP9DPP7ALDH1A1 | |
| SCHEMBL29630471 | 0.94 | NPY4R (0.53) | GSRDPP8DPP9DPP7ALDH1A1 | |
| SCHEMBL31573967 | 0.93 | NMT2 (0.48) | GSRDPP8DPP9DPP7ALDH1A1 | |
| SCHEMBL31343172 | 0.93 | NPY4R (0.52) | GSRDPP8DPP9DPP7ERAP2 | |
| SCHEMBL29404079 | 0.93 | NPY4R (0.52) | GSRDPP8DPP9DPP7ERAP2 | |
| SCHEMBL29384387 | 0.92 | NTSR2 (0.45) | GSRDPP8DPP9DPP7ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3497114-B1 | ANDROGEN RECEPTOR ANTISENSE OLIGONUCLEOTIDES | OLIPASS CORP (KR) | 2024-10-16 | — | — | EP | claimed |
| EP-4424365-A2 | PET FOOD COMPOSITIONS | Hill's Pet Nutrition, Inc. (US) | 2024-09-04 | — | — | EP | claimed |
| EP-4017281-B1 | PET FOOD COMPOSITIONS | HILLS PET NUTRITION INC (US) | 2024-08-28 | — | — | EP | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| CN-116448932-A | Analysis method for chemical components of periplaneta americana extract CII-3 | 大理大学 | 2023-07-18 | — | — | CN | claimed |
| EP-3512870-B1 | SCN9A ANTISENSE OLIGONUCLEOTIDES | OLIPASS CORP (KR) | 2022-08-03 | — | — | EP | claimed |
| CN-114828648-A | Pet food compositions | 希尔氏宠物营养品公司 | 2022-07-29 | — | — | CN | claimed |
| EP-4017281-A1 | PET FOOD COMPOSITIONS | Hill's Pet Nutrition, Inc. (US) | 2022-06-29 | — | — | EP | claimed |
| US-11319540-B2 | HIF 1-alpha antisense oligonucleotides | OLIPASS CORPORATION (KR) | 2022-05-03 | — | — | US | claimed |
| US-20220088113-A1 | SPECIFIC PEPTIDE CLATHRIN INHIBITORS | KOTIN, Oleg Arkadyevich (RU) | 2022-03-24 | — | — | US | claimed |
| US-11261448-B2 | SNAP25 antisense oligonucleotides | OLIPASS CORPORATION (KR) | 2022-03-01 | — | — | US | claimed |
| CN-112501269-B | Method for rapidly identifying high-affinity TCR antigen cross-reactivity | 清华大学 | 2022-02-18 | — | — | CN | claimed |
| EP-2185552-B1 | DIPEPTOID PRODRUGS AND THE USE THEREOF | BAYER IP GMBH (DE) | 2014-03-12 | — | — | EP | claimed |
| CN-122075727-A | Subcellular targeting drug delivery conjugate, preparation method, composition and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| WO-2026107097-A1 | SELF-IMMOLATIVE LINKERS AND CONJUGATES THEREOF | ENLAZA THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| WO-2026103740-A1 | CEACAM5-ANTIGEN-TARGETING ANTIBODY, ANTIBODY-DRUG CONJUGATE THEREOF AND USE THEREOF | 信达生物医药科技(杭州)有限公司 | 2026-05-21 | — | — | WO | disclosed |
| EP-0767797-A4 | PLANT PEPTIDE TRANSPORT GENE | UNIV TENNESSEE RES CORP (US) | 1998-06-10 | — | — | EP | disclosed |
| US-5689039-A | HERBICIDE RESISTANCE | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 1997-11-18 | — | — | US | disclosed |
| EP-0767797-A1 | PLANT PEPTIDE TRANSPORT GENE | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 1997-04-16 | — | — | EP | disclosed |
| WO-1995025114-A1 | PLANT PEPTIDE TRANSPORT GENE | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 1995-09-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11319540-B2 | HIF 1-alpha antisense oligonucleotides | HIF1A, HIF1AN, UPF1 | GSR 2645/4885DPP8 1032/4885DPP9 1723/4885 |
| US-11261448-B2 | SNAP25 antisense oligonucleotides | RBM25, SNAP23, UPF1 | GSR 4726/4885DPP8 1309/4885DPP9 1624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.